- Home
- SINT vs IMNN Comparison
SINT vs IMNN Comparison
Compare SINT & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SINT
- IMNN
- Stock Information
- Founded
- SINT 1996
- IMNN 1982
- Country
- SINT United States
- IMNN United States
- Employees
- SINT N/A
- IMNN N/A
- Industry
- SINT Medical/Dental Instruments
- IMNN Biotechnology: Pharmaceutical Preparations
- Sector
- SINT Health Care
- IMNN Health Care
- Exchange
- SINT Nasdaq
- IMNN Nasdaq
- Market Cap
- SINT 11.6M
- IMNN 12.9M
- IPO Year
- SINT 2014
- IMNN 1985
- Fundamental
- Price
- SINT $3.74
- IMNN $4.86
- Analyst Decision
- SINT Strong Buy
- IMNN Buy
- Analyst Count
- SINT 1
- IMNN 2
- Target Price
- SINT $25.00
- IMNN $182.61
- AVG Volume (30 Days)
- SINT 440.1K
- IMNN 87.4K
- Earning Date
- SINT 11-11-2025
- IMNN 11-05-2025
- Dividend Yield
- SINT N/A
- IMNN N/A
- EPS Growth
- SINT N/A
- IMNN N/A
- EPS
- SINT N/A
- IMNN N/A
- Revenue
- SINT $1,861,000.00
- IMNN N/A
- Revenue This Year
- SINT N/A
- IMNN N/A
- Revenue Next Year
- SINT $80.00
- IMNN N/A
- P/E Ratio
- SINT N/A
- IMNN N/A
- Revenue Growth
- SINT N/A
- IMNN N/A
- 52 Week Low
- SINT $1.71
- IMNN $4.60
- 52 Week High
- SINT $8.60
- IMNN $41.22
- Technical
- Relative Strength Index (RSI)
- SINT 46.38
- IMNN 41.15
- Support Level
- SINT $3.10
- IMNN $4.66
- Resistance Level
- SINT $4.13
- IMNN $5.19
- Average True Range (ATR)
- SINT 0.41
- IMNN 0.31
- MACD
- SINT -0.09
- IMNN -0.01
- Stochastic Oscillator
- SINT 42.19
- IMNN 33.75
About SINT SiNtx Technologies Inc.
SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).